1,046 results on '"Mazzone E"'
Search Results
202. Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: a stage-specific analysis from a large multi-institutional series
203. The role of intraoperative indocyanine green in robot-assisted partial nephrectomy: results from a large, multi-institutional series
204. Should we target all visible areas at mpMRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series
205. The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with oligometastatic prostate cancer: an external validation study
206. The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer
207. Is focal ablation as effective as hemi-ablation? analysis of treatment patterns over 12 years from a high volume centre for focal therapy
208. Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance. results from a single institution series
209. Cure without toxicity: development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
210. Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series
211. A positive PSMA PET/CT Predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
212. The iron study: investigation of robot-assisted versus open nephron-sparing surgery
213. Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer
214. Regression-tree analysis for identifying the best candidates to neoadjuvant chemotherapy in patients with clinical node-positive penile squamous-cell carcinoma
215. Oncological and functional outcomes of cytoreductive radical prostatectomy (cRP) in men with metastatic hormone-naive prostate cancer (mhnPCA)
216. Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: A stage-specific analysis from a large multi-institutional series
217. Risk adapted comparison between cancer recurrence and non-cancer related death in patients treated with robot-assisted radical cystectomy for muscle invasive bladder cancer
218. Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance: Results from a single institution series
219. A positive PSMA PET/CT predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
220. Should we target all visible areas at mp-MRI suspicious for clinically significant prostate cancer in addition to the index lesion? Results from a two-institution series
221. Assessing the impact of salvage radiation therapy field after radical prostatectomy: A long-term analysis from a large multi-institutional series
222. Robotic radical nephroureterectomy for upper tract urothelial carcinoma: Data from the ROBotic surgery for Upper tract Urothelial cancer STudy (ROBUUST) collaborative group
223. Robot-assisted radical cystectomy with intracorporeal urinary diversion decreases post-operative complications only in highly comorbid patients: Findings that rely on a standardized methodology recommended by European Association of Urology guidelines
224. Removing the nodes that count rather than counting the nodes that don’t: Importance of refining sentinel node identification to reduce morbidity in penile cancer patients
225. Robot-assisted tension free surgery in distal ureteral disease
226. Technical innovations of modified apical dissection and lateral prostatic fascia preservation improves early postoperative functional recovery in robotic assisted laparoscopic radical prostatectomy
227. Adoption of a new robotic platform. Key technical modifications: A step-by-step approach to da Vinci SP radical prostatectomy
228. Safety profile of robotic vs. laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: Data from the Robotic Surgery for Upper Tract Urothelial Cancer Study (ROBUUST) collaborative group
229. The role of Indocyanine Green (ICG) in guiding robot-assisted partial nephrectomy: A prospective multi-institutional TRONES study
230. Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series
231. Validation of hybrid ICG-99mTc-nanocolloid for sentinel node biopsy in a large cohort of penile cancer patients: Improved sentinel node detection compared to blue dye
232. How can we increase the positive predictive value of PIRADS 4 and 5 lesions at mp-MRI? Development of a novel prediction tool relying on a large, multi-institutional series
233. Are men with low risk prostate cancer but high PIRADS score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatectomy series
234. First international workshop on rehabilitation management and clinical outcome measures for spinal muscular atrophy
235. Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy
236. Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683)
237. VE31 - 99m-Technetium-PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing with radical prostatectomy and extended pelvic lymph node dissection
238. PE55 - The impact of cumulative smoking status on perioperative morbidity after robot-assisted radical cystectomy
239. PE48 - Long-term oncologic outcomes of robot-assisted radical cystectomy: Update series from an high-volume robotic center beyond 10 years of follow-up
240. SC270 - Definition and predictors of upgrading at final pathology in prostate cancer patients undergoing MRI-targeted and systematic biopsies: results from a large, multi-institutional series
241. SC269 - When node-positive prostate cancer should be considered a systemic disease? assessing the prognostic role of preoperative 68Ga-PSMA PET/ CT results in patients with lymph node invasion at final pathology
242. SC275 - The risk of recurrence in cN1 prostate cancer patients treated with radical prostatectomy varies according to the type preoperative staging. a comparison between 68ga-PSMA-PET versus conventional imaging in a large, multi-institutional study
243. SC274 - How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: a novel risk stratification tool
244. SC271 - Added value of mpmri in the stratification of patients with high-risk patients prostate cancer treated with radical prostatectomy: implications for tailored multi-modal strategies
245. SC273 - Does a positive multi-parametric MRI always warrant prostate biopsy? the importance of integrating clinical and imaging data based on a large, multi-institutional series
246. SC272 - The prognostic value of the number of positive targeted cores in men with positive multiparametric magnetic resonance imaging of the prostate. results from a large, multi-institutional series
247. SC267 - 99M-technetium-psma radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection: a phase 2 prospective, single-institution study
248. SC232 - Outcomes of prostate cancer patients with seminal vesicle invasion at multiparametric MRI managed with radical prostatectomy. Do all patients really need for a multi-modal approach?
249. SC242 - Increased awareness of surgical outcomes improves long-term functional outcomes after robot-assisted radical prostatectomy. A prospective assessment following implementation of prospective data collection
250. SC243 - A timely administration of metastasis-directed therapy can reduce the risk of disease progression in men with positive 68Ga-PSMA PET/CT for biochemical recurrence after radical prostatectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.